Buscar
Mostrando ítems 1-3 de 3
Clinical implementation of PLANET® Dose for dosimetric assessment after [177Lu]Lu-DOTA-TATE: comparison with Dosimetry Toolkit® and OLINDA/EXM® V1.0
(2021)
The aim of this study was to compare a commercial dosimetry workstation (PLANET® Dose) and the dosimetry approach (GE Dosimetry Toolkit® and OLINDA/EXM® V1.0) currently used in our department for quantification of the ...
Implementation of patient dosimetry in the clinical practice after targeted radiotherapy using [177Lu-[DOTATO,Tyr3]-octreotate
(2018-11-29)
Background: This study’s aim was to develop our dosimetric methodology using a commercial workstation for the
routine evaluation of the organs at risk during peptide receptor radionuclide therapy (PRRT) with 177Lu.
Methods: ...
Comparison of commercial dosimetric software platforms in patients treated with 177Lu-DOTATATE for peptide receptor radionuclide therapy
(2020)
Purpose
The aim of this study was to quantitatively compare five commercial dosimetric software platforms based on the analysis of clinical datasets of patients who benefited from peptide receptor radionuclide therapy ...